Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT02680587.
ClinicalTrials.gov Identifier: NCT02680587.
Abstract Purpose Genomic classifiers are endorsed by guidelines and commonly used to inform prognosis in prostate cancer. We aimed to understand the distribution of genomic risk...
h-index: Number of publications with at least h citations each.